|
Legaz I, Jimenez-Coll V, Gonzalez-Lopez R, Fernandez-Gonzalez M, Alegria-Marcos MJ, Galian JA, Botella C, Moya-Quiles R, Muro-Perez M, Minguela A, Llorente S, Muro M. MicroRNAs as Potential Graft Rejection or Tolerance Biomarkers and Their Dilemma in Clinical Routines Behaving like Devilish, Angelic, or Frightening Elements. Biomedicines. 2024 Jan 5;12(1):116. doi: 10.3390/biomedicines12010116. PubMed PMID: 38255221; PubMed Central PMCID: PMC10813128.
AÑO: 2024; IF: 3.9
|
38255221
|
Moya-Quiles MR, Muro M. Identification of six new HLA-C variants with nucleotide changes in non-coding regions. HLA. 2024 Sep;104(3):e15692. doi: 10.1111/tan.15692. PubMed PMID: 39291365.
AÑO: 2024; IF: 4.1
|
|
Novoa-Bolivar EM, Ros JA, Perez-Fernandez S, Campillo JA, Lopez-Hernandez R, Gonzalez-Lopez R, Otalora-Alcaraz A, Ortuno-Hernandez C, Gimeno L, Ruiz-Lorente I, Ceballos-Francisco D, Muro M, Solana E, Martinez-Camblor P, Minguela A. Predictive Value of Flow Cytometry Quantification of BAL Lymphocytes and Neutrophils in ILD. Cells. 2024 Dec 13;13(24):2066. doi: 10.3390/cells13242066. PubMed PMID: 39768157; PubMed Central PMCID: PMC11674578.
AÑO: 2024; IF: 5.2
|
|
Collados-Ros A, Muro M, Legaz I. Gemtuzumab Ozogamicin in Acute Myeloid Leukemia: Efficacy, Toxicity, and Resistance Mechanisms-A Systematic Review. Biomedicines. 2024 Jan 17;12(1):208. doi: 10.3390/biomedicines12010208. PubMed PMID: 38255313; PubMed Central PMCID: PMC10813452.
AÑO: 2024; IF: 3.9
|
|
Moya-Quiles MR, Muro M. Identification of the novel HLA-C*08:291 allele by next-generation sequencing. HLA. 2024 Sep;104(3):e15689. doi: 10.1111/tan.15689. PubMed PMID: 39279454.
AÑO: 2024; IF: 4.1
|